Molecular cytogenetic aberrations in 21 Chinese patients with plasma cell leukemia

International Journal of Laboratory Hematology

Volumn 31, Issue 3, 2009, Pages 338-343

  Xu, W ^a   Li, J Y ^a   Fan, L ^a   Chen, L J ^a   Qiu, H R ^a   Qiu, H X ^a   Lu, H ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cytogenetic abnormality; Fluorescence in situ hybridization; Plasma cell leukemia

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CHINESE; CHROMOSOME 1; CHROMOSOME 13Q; CHROMOSOME 16P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MALE; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL;

ADULT; AGED; CHINA; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 14; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, PLASMA CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 65349189899     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2008.01037.x     Document Type: Article

References (16)

1. Agnelli L., Bicciato S., Mattioli M., Fabris S., Intini D., Verdelli D., Baldini L., Morabito F., Callea V., Lombardi L. Neri A. (2005) Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations. Journal of Clinical Oncology 23, 7296 7306.
2. Avet-Loiseau H., Facon T., Grosbois B., Magrangeas F., Rapp M.J., Harousseau J.L., Minvielle S. Bataille R. (2002) Intergroupe Francophone du Myelome. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood 99, 2185 2191.
3. Chang H., Bouman D., Boerkoel C.F., Stewart A.K. Squire J.A. (1999) Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization. Leukemia 13, 105 109.
4. Chang H., Li D., Zhuang L., Nie E., Bouman D., Stewart A.K. Chun K. (2004) Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis. Leukaemia & Lymphoma 45, 965 969.
5. Fonseca R., Oken M.M. Greipp P.R. (2001) The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathies of undetermined significance. Blood 98, 1271 1272.
6. Fonseca R., Harrington D., Oken M.M., Dewald G.W., Bailey R.J., Van Wier S.A., Henderson K.J., Blood E.A., Rajkumar S.V., Kay N.E., Van Ness B. Greipp P.R. (2002) Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study. Cancer Research 62, 715 720.
7. Garcia-Sanz R., Orfao A., Gonzalez M., Tabernero M.D., Blade J., Moro M.J., Fernandez-Calvo J., Sanz M.A., Perez-Simon J.A., Rasillo A. Miguel J.F. (1999) Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. Blood 93, 1032 1037.
8. Hoyer J.D., Hanson C.A., Fonseca R., Greipp P.R., Dewald G.W. Kurtin P.J. (2000) The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study. American Journal of Clinical Pathology 113, 831 837.
9. Jonveaux P. Berger R. (1992) Chromosome studies in plasma cell leukemia and multiple myeloma in transformation. Genes, Chromosomes and Cancer 4, 321 325.
10. Keats J.J., Reiman T., Maxwell C.A., Taylor B.J., Larratt L.M., Mant M.J., Belch A.R. Pilarski L.M. (2003) In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression. Blood 101, 1520 1529.
11. Kyle R.A., Maldonado J.E. Bayrd E.D. (1974) Plasma cell leukemia. Report on 17 cases. Archives of Internal Medicine 133, 813.
12. Lloveras E., Granada I., Zamora L., Espinet B., Florensa L., Besses C., Xandri M., Perez-Vila M.E., Milla F., Woessner S. Sole F. (2004) Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemia. Cancer Genetics and Cytogenetics 148, 71 76.
13. Nishida K., Tamura A., Nakazawa N., Ueda Y., Abe T., Matsuda F., Kashima K. Taniwaki M. (1997) The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood 90, 526 534.
14. Rasillo A., Tabernero M.D., Sanchez M.L., Perez de Andres M., Martin Ayuso.M., Hernandez J., Moro M.J., Fernandez-Calvo J., Sayagues J.M., Bortoluci A., San Miguel J.F. Orfao A. (2003) Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia. Cancer 97, 601 609.
15. Shaughnessy J. Jr., Tian E., Sawyer J., McCoy J., Tricot G., Jacobson J., Anaissie E., Zangari M., Fassas A., Muwalla F., Morris C. Barlogie B. (2003) Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II. British Journal of Haematology 120, 44 52.
16. Shaughnessy J.D. Jr., Zhan F., Burington B.E., Huang Y., Colla S., Hanamura I., Stewart J.P., Kordsmeier B., Randolph C., Williams D.R., Xiao Y., Xu H., Epstein J., Anaissie E., Krishna S.G., Cottler-Fox M., Hollmig K., Mohiuddin A., Pineda-Roman M., Tricot G., van Rhee F., Sawyer J., Alsayed Y., Walker R., Zangari M., Crowley J. Barlogie B. (2007) A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood 109, 2276 2284.